President Donald Trump (Trump) revealed on Saturday (Nov. 14) that New York State may get the vaccine for the Chinese Communist virus (neocoronavirus) later than other states because New York Governor Andrew Cuomo declared that New York State will not begin using the drug right away.
Cuomo tweeted on Saturday, “I love New York! As we all know, the Trump administration has produced a great and safe vaccine well ahead of the expected deadline. If it were another administration, it would have taken five years.” “The problem is that Kummer says he will delay its use, while other states want the vaccine now.”
The president added: “We can’t waste time and only give the vaccine to those states that would use it immediately, so New York will delay getting it. Many lives need to be saved and we are ready for that. Let’s stop playing politics! “
Trump also made special mention of New York during a press conference on Friday (Nov. 13). The conference was about the administration’s Operation Warp Speed program, which aims to rapidly distribute new vaccines against the Chinese Communist virus. The president said, “Kummer has to let us know when he’s ready, otherwise we can’t give the vaccine to a state that won’t give it to the people right away.”
Kummer has repeatedly questioned the efficacy of the new vaccine that the Trump administration has pushed to develop. He claimed on CNN on Friday that while Americans trust the companies developing the vaccines, they are concerned that the vaccine approval process has become politicized.
Kummer said, “We’re in a situation where half the country is saying, ‘I don’t know if I should trust this vaccine,'”
Kummer told ABC last week that he is in discussions with other governors about modifying or halting the president’s plan to distribute vaccines. In September, New York’s governor established an independent commission to review the effectiveness and safety of the new vaccine. Similar steps have been taken in California, Washington, Oregon and Nevada.
On Nov. 9, Pfizer announced that data from a late-stage study showed that the company’s vaccine was 90 percent effective in preventing infection with the Chinese Communist virus.
In July, the U.S. government reached an agreement with Pfizer and BioNTech, agreeing to pay $1.95 billion for the first 100 million doses of the BNT162 vaccine introduced by the two companies. The deal is still subject to approval or emergency use authorization from the U.S. Food and Drug Administration (FDA), which has not yet been granted.
Recent Comments